1. Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer
   Naoki Kawahara et al, 2017, Biomedical Reports CrossRef
2. Conceptual frameworks of synthetic lethality in clear cell carcinoma of the ovary (Review)
   Hiroshi Kobayashi et al, 2018, Biomedical Reports CrossRef
3. Clinical Development of CHK1 Inhibitors
   Alvaro Ingles Garces et al, 2018, Targeting the DNA Damage Response for Anti-Cancer Therapy CrossRef
4. Aktuelle Aspekte der Diagnostik von Ovarialtumoren
   E. T. Taube et al, 2019, Der Onkologe CrossRef
5. Bayesian Inference of Hub Nodes Across Multiple Networks
   Junghi Kim et al, 2019, Biometrics CrossRef
6. The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
   Fuminori Ito et al, 2018, Oncotarget CrossRef
7. Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency
   Rebecca S. Kristeleit et al, 2016, American Society of Clinical Oncology Educational Book CrossRef
8. New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment
   Biqing Chen et al, 2024, Frontiers in Oncology CrossRef